Restricted accessResearch articleFirst published online 2012-7
Prolonged use of extracorporeal membrane oxygenation combined with prone positioning in patients with acute respiratory distress syndrome and invasive Aspergillosis
Extracorporeal membrane oxygenation (ECMO) is increasingly being used in patients with severe acute respiratory distress syndrome. In two large cohorts of such patients, the median duration of treatment with ECMO was 9 and 10 days.
We describe two patients, both with H1N1 pneumonia complicated by invasive Aspergillosis, who required ECMO support significantly longer at 45 and 52 days, but eventually made a full recovery. In both patients, prone positioning was used during ECMO treatment.
RubenfeldGCaldwellEPeabodyE. Incidence and outcomes of acute lung injury. N Engl J Med2005, 353: 1685–1693.
2.
PeekJMugfordMTiruvoipatiR. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet2009; 374: 1351–1363.
3.
The Australia and New Zealand ECMO influenza investigators. Extracorporeal membrane oxygenation for 2009 influenza (h1N1) acute respiratory distress syndrome. JAMA2009; 302: 1888–1895.
CarfagnaPBrandimarteFCacceseRCampagnaDBrandimarteCVendittiM.Occurrence of influenza A(H1N1)v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Mycoses2011Nov; 54(6): 549–551. Epub 2011 May 23.
6.
McCunnMReynoldsHNCottinghamCAScaleaTMHabashiNM.Extracorporeal support in an adult with severe carbon monoxide poisoning and shock following smoke inhalation. Perfusion2000; 15: 169–173.
